SeaStar Medical Holding Corporation - Equity Warrant
US ˙ NasdaqCM ˙ US81256L1127

Introduction

This page provides a comprehensive analysis of the known insider trading history of Kevin Chung. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Kevin Chung has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ICU / SeaStar Medical Holding Corporation Chief Medical Officer 58,184
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Kevin Chung. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ICUCW / SeaStar Medical Holding Corporation - Equity Warrant - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ICUCW / SeaStar Medical Holding Corporation - Equity Warrant. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-08-22 ICU Chung Kevin 10,000 0.8000 10,000 0.8000 8,000 7 0.9161 1,161 14.51
2025-05-20 ICU Chung Kevin 4,500 1.2500 4,500 1.2500 5,625
2024-11-18 ICU Chung Kevin 4,250 1.9900 4,250 1.9900 8,458
2024-09-30 ICU Chung Kevin 1,000 4.2581 1,000 4.2581 4,258
2023-05-30 ICU Chung Kevin 5,093 0.4700 204 11.7500 2,394
2023-05-30 ICU Chung Kevin 4,000 0.4800 160 12.0000 1,920
2023-05-30 ICU Chung Kevin 2,300 0.4750 92 11.8750 1,092
2023-05-30 ICU Chung Kevin 1,150 0.4751 46 11.8775 546
2023-05-18 ICU Chung Kevin 7,500 0.6998 300 17.4950 5,248
2022-04-05 ICU Chung Kevin 3,760 1.8500 150 46.2500 6,956

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ICUCW / SeaStar Medical Holding Corporation - Equity Warrant Insider Trades
Insider Sales ICUCW / SeaStar Medical Holding Corporation - Equity Warrant - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ICUCW / SeaStar Medical Holding Corporation - Equity Warrant. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ICUCW / SeaStar Medical Holding Corporation - Equity Warrant Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Kevin Chung as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-25 2025-08-22 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 10,000 58,184 20.75 0.80 8,000 46,547
2025-07-03 2025-07-01 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
M - Exercise 5,000 48,184 11.58
2025-05-20 2025-05-20 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 4,500 18,185 32.88 1.25 5,625 22,731
2024-11-19 2024-11-18 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 4,250 13,685 45.05 1.99 8,458 27,233
2024-10-01 2024-09-30 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 1,000 9,435 11.86 4.26 4,258 40,175
2023-11-29 2023-11-29 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
A - Award 63,422 210,860 43.02
2023-11-28 2023-08-31 4/A ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
A - Award 28,125 113,181 33.07
2023-09-19 2023-09-15 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
A - Award 34,257 154,490 28.49
2023-09-12 2023-08-31 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
A - Award 35,178 120,233 41.36
2023-08-17 2023-08-15 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
A - Award 16,930 85,055 24.85
2023-06-01 2023-05-30 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 1,150 68,125 1.72 0.48 546 32,366
2023-06-01 2023-05-30 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 2,300 66,975 3.56 0.48 1,092 31,813
2023-06-01 2023-05-30 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 4,000 64,675 6.59 0.48 1,920 31,044
2023-06-01 2023-05-30 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 5,093 60,675 9.16 0.47 2,394 28,517
2023-05-22 2023-05-18 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 7,500 55,582 15.60 0.70 5,248 38,896
2023-04-07 2022-04-06 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
A - Award 44,322 48,082 1,178.78
2023-04-07 2022-04-05 4 ICU SeaStar Medical Holding Corp
Common Stock, par value $0.0001 per share
P - Purchase 3,760 3,760 1.85 6,956 6,956
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)